GPCRs session icon

GPCRs in Addiction

  • Chair(s):

    Andrew Lawrence,
    Division Head, Florey Institute of Neuroscience & Mental Health, Parkville, Australia

    Chris Langmead ,
    Monash Institute of Pharmaceutical Sciences, Parkville, Australia

  • Session description:

    Development of novel GPCR therapeutics for substance use disorders
    Professor Paul Kenny
    Director, Drug Discovery Institute, Icahn School of Medicine at Mt Sinai, NY, The United States of America

    The role of muscarinic receptors in alcohol seeking
    Dr Leigh Walker
    Florey Institute of Neuroscience & Mental Health, University of Melbourne, Parkville, Australia

    Oral communication speaker - to be confirmed in 2022.

    Targeting GABA-B receptors for treatment of alcohol addiction
    Professor Markus Heilig
    Linköping University, Linköping , Sweden

    Metabotropic glutamate receptor modulation of striatal circuits involved in reinforcement learning and addiction
    Dr Kari Johnson
    Uniformed Services University of the Health Sciences, Bethesda, The United States of America

    Sponsored by:

    the British Journal of Pharmacology


05 Jul 2023


9:45 am - 12:10 pm


Go to Top